Pacific Biosciences of California (PACB) said Tuesday it was selected by the Davos Alzheimer's Collaborative as a technology partner for its North African Dementia Registry project.
The partnership will utilize Pacific Biosciences of California's sequencing technology to develop genetic insights into the factors contributing to Alzheimer's disease and dementia for future research, prevention, and treatment efforts, according to a company statement.
The collaboration is expected to address the underrepresentation of North African populations in dementia research and build a comprehensive dataset to further the research community's understanding of the disease, the company said.
Shares were up over 2% in recent Tuesday trading.
Price: 1.17, Change: +0.03, Percent Change: +2.63
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。